Kiniksa Pharmaceuticals International, plc (KNSA)

KNSA Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	192.04	183.58	107.95	122.72	122.47	114.04
Short-Term Investments	115.75	60.05	98.42	67.89	59.73	209.44
Cash & Short-Term Investments	307.78	243.63	206.37	190.61	182.2	323.48
Cash Growth	40.70%	18.05%	8.27%	4.61%	-43.68%	38.61%
Receivables	31.91	41.72	21.27	20.32	3.99	-
Inventory	48.18	26.36	31.12	21.6	3.68	-
Prepaid Expenses	32.44	20.08	17.54	10.54	6.59	9.56
Restricted Cash	-	-	-	-	-	0.21
Total Current Assets	420.31	331.8	276.3	243.06	196.45	333.25
Property, Plant & Equipment	11.38	11.04	12.67	7.04	8.38	10.62
Other Intangible Assets	15.75	16.25	17.25	18.25	19.25	-
Long-Term Deferred Tax Assets	205.51	211.15	219.28	185.5	-	0.01
Other Long-Term Assets	8.2	10.32	0.83	5.82	8.72	5.59
Total Assets	661.15	580.55	526.32	459.67	232.8	349.46
Accounts Payable	8.96	2.04	8.25	7.9	1.87	0.5
Accrued Expenses	88.35	80.51	44.67	30.11	38.03	29.2
Current Portion of Leases	2.52	1.99	2.25	3.3	3.38	2.11
Current Unearned Revenue	-	-	0.31	-	-	-
Other Current Liabilities	18	16.08	8.19	5.75	1.54	0.04
Total Current Liabilities	117.83	100.62	63.67	47.07	44.82	31.85
Long-Term Leases	7.24	7.86	10.01	2.62	2.67	4.88
Long-Term Unearned Revenue	31.81	31.81	11.95	12	-	-
Other Long-Term Liabilities	9.26	1.82	1.86	1.84	0.27	0.81
Total Liabilities	166.14	142.12	87.48	63.52	47.76	37.53
Common Stock	0.02	0.02	0.02	0.02	0.02	0.02
Additional Paid-In Capital	989.81	959.72	916.76	888.12	860.48	829.42
Retained Earnings	-494.77	-521.14	-477.95	-492.03	-675.4	-517.47
Comprehensive Income & Other	-0.05	-0.16	0.01	0.04	-0.07	-0.03
Total Common Equity	495.01	438.44	438.84	396.15	185.04	311.94
Shareholders' Equity	495.01	438.44	438.84	396.15	185.04	311.94
Total Liabilities & Equity	661.15	580.55	526.32	459.67	232.8	349.46
Total Debt	9.77	9.86	12.26	5.92	6.05	6.99
Net Cash (Debt)	298.02	233.77	194.11	184.69	176.15	316.5
Net Cash Growth	43.72%	20.43%	5.10%	4.85%	-44.34%	37.17%
Net Cash Per Share	4.00	3.27	2.70	2.62	2.57	5.12
Filing Date Shares Outstanding	74.11	72.64	70.62	69.75	69.1	68.23
Total Common Shares Outstanding	74.03	72.52	70.46	69.7	69.06	68.22
Working Capital	302.48	231.18	212.63	195.99	151.62	301.4
Book Value Per Share	6.69	6.05	6.23	5.68	2.68	4.57
Tangible Book Value	479.26	422.19	421.59	377.9	165.79	311.94
Tangible Book Value Per Share	6.47	5.82	5.98	5.42	2.40	4.57
Machinery	4.3	4.77	4.58	4.59	4.65	5.01
Construction In Progress	0.63	0.16	0.01	-	0.17	0.1
Leasehold Improvements	3.92	3.93	3.93	3.93	3.93	3.67

Updated Jul 29, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q